Turmalina Metals Announces AGM Results
TSX VENTURE: TBX
Mr. Bryan Slusarchuk reports:
VANCOUVER, British Columbia, July 31, 2020 (GLOBE NEWSWIRE) -- Turmalina Metals Corp. (“Turmalina”, or the “Company”; TBX-TSXV, TBXXF-OTCQX) is pleased to announce voting results of its annual general meeting of shareholders (AGM) that was held on July 29, 2020.
At the AGM, shareholders set the size of the board of directors at five. Detailed voting results regarding the election of directors are as set out in the following table:
Director nominee Number of shares
voted for % of shares
voted for Number of shares
voted withheld % of shares
Rohan Wolfe 9,891,802 99.94 6,300 0.06
Bryan Slusarchuk 9,891,802 99.94 6,300 0.06
Francisco Azevedo, Jr. 9,891,802 99.94 6,300 0.06
Mark Eaton 9,891,802 99.94 6,300 0.06
Miguel Inchaustegui 9,891,802 99.94 6,300 0.06
Shareholders also approved:
The appointment of Davidson & Company LLP as the auditor of Turmalina Metals for the ensuing fiscal year;
Authorization for the directors to fix the remuneration paid to the auditor; and
A resolution authorizing the continuation of Turmalina Metal Corp.’s rolling stock option plan.
Turmalina is currently conducting Phase Two drilling at the Company’s San Francisco Project located in the mining friendly jurisdiction of San Juan, Argentina. The program is targeting vertical and lateral extensions of the SFdLA breccia, where multiple high-grade gold-silver-copper intercepts were reported in Phase One drilling, as well as several new high-priority breccia targets identified during the company’s extensive summer field program (see Turmalina News Release dated June 24, 2020 for more details).
In excess of 2,000 metres of drilling has been completed to date during Phase Two drilling and the company has two drill rigs turning. Cutting and logging of the drill core is progressing smoothly: core deliveries to the assay lab will commence today and will be ongoing over the next two months. Assay results will be released as they are received and assessed.
On Behalf of the Company,
Dr. Rohan Wolfe, Chief Executive Officer and Director.